AsianScientist (Oct. 27, 2016) – The QIMR Berghofer Medical Research Institute and Chinese genomics organization BGI have entered into an agreement that will promote collaboration on a genomics-based research and education program.
Professor Frank Gannon, director and CEO of QIMR Berghofer, said that under the agreement both organizations would work towards establishing a joint research program focused on precision medicine and the use of ’omics data.
Precision medicine is a fast-growing field of research that involves developing personalized treatments for individual patients based on the particular genetic drivers or cellular makeup of their cancer or disease, according to Gannon.
Indeed, in August, BGI announced that it had chosen QIMR Berghofer as its research and development and commercialization headquarters for the Asia Pacific region.
Professor Wang Jian, president and co-founder of BGI, said that under the Memorandum of Understanding, the two organizations would explore a range of options to encourage research collaboration.
Source: QIMR Berghofer.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.